EP3518897

OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    30.9.2017
  • :
    9.2.2022
  • :
    17857601.3
  • :
    29.9.2037
  • :
    OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF

30.9.2017
9.2.2022
  • :
    Mati Therapeutics Inc.
  • :
    4317 Dunning Lane, Austin, TX 78746, US
  • :
    UTKHEDE, Deepank
  • :
    Burnaby, British Columbia V5G 4X4, CA
  • :
    JONES, Catherine
  • :
    Burnaby, British Columbia V5G 4X4, CA
  • :
    WISEMAN, David
  • :
    Burnaby, British Columbia V5G 4X4, CA
  • :
    201662402938 P
  • :
    30.9.2016
  • :
    US
  • :
    US2017054654
  • :
    30.9.2017
  • :
    A61K 9/14, A61K 47/34, A61K 47/10, A61K 31/165, A61K 38/13, A61F 9/00, A61L 27/54